Fast multimodal imaging combined with machine learning identifying taurine as a potential marker for breast cancer margin assessment - Scorecard - MDSpire
Advertisement
Fast multimodal imaging combined with machine learning identifying taurine as a potential marker for breast cancer margin assessment
Clinical Scorecard: Rapid multimodal imaging integrated with machine learning reveals taurine as a potential biomarker for assessing breast cancer surgical margins
At a Glance
Category
Detail
Condition
Breast cancer (BC)
Key Mechanisms
Integration of femtosecond label-free imaging (FLI) microscopy and imaging mass spectrometry (IMS) with machine learning (ML) to detect surgical margins using cellular morphology and metabolite profiles, identifying taurine as a biomarker
Target Population
Patients undergoing breast-conserving surgery (BCS) for early-stage breast cancer
Care Setting
Intraoperative surgical setting and pathology departments
Key Highlights
FLI microscopy enables rapid, label-free visualization of cellular structures in fresh and fixed breast tissues without sectioning or staining.
A biomarker panel including taurine, threonate, and glutamate differentiates breast cancer from tumor-adjacent noncancerous breast tissues.
Elevated taurine levels correlate with positive surgical margins and poor overall survival, suggesting its utility as an intraoperative biomarker.
Guideline-Based Recommendations
Diagnosis
Use multimodal imaging combining FLI microscopy and IMS for rapid margin assessment during breast-conserving surgery.
Apply machine learning algorithms to classify cancerous versus noncancerous tissue based on metabolite profiles.
Management
Incorporate taurine level measurement intraoperatively to guide surgical margin evaluation and reduce positive margin rates.
Utilize rapid imaging techniques to minimize re-excision rates and optimize surgical outcomes.
Monitoring & Follow-up
Monitor taurine abundance as a potential prognostic marker linked to overall survival in breast cancer patients.
Risks
Recognize limitations of current intraoperative margin assessment methods such as frozen section analysis, which are time-consuming and require skilled pathologists.
Address the challenge of positive margins (~20-40%) leading to reoperations by adopting more sensitive and specific biomarker-based techniques.
Patient & Prescribing Data
Patients undergoing breast-conserving surgery for early-stage breast cancer
Real-time intraoperative assessment of surgical margins using taurine as a biomarker may reduce re-excision rates and improve patient outcomes.
Clinical Best Practices
Employ femtosecond label-free imaging microscopy for rapid, high-resolution visualization of breast tissue morphology intraoperatively.
Integrate imaging mass spectrometry with machine learning to identify metabolic biomarkers distinguishing cancerous from noncancerous tissue.
Use taurine abundance as a biomarker to assess margin status and guide surgical decision-making during breast-conserving surgery.
